Reporting Manager
Integrated Core Strategies (US) LLC
Symbol
UNCY
Shares outstanding
21,321,218 shares
Disclosed Ownership
1,172,667 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
23 Jan 2026, 16:41:09 UTC
Date of event
16 Jan 2026

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.5% ownership in Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY) on 16 Jan 2026."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY).
  • Disclosed ownership: 5.5%.
  • Date of event: 16 Jan 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 23 Jan 2026, 16:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.5% 1,172,667 0 1,172,667 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.5% 1,172,667 0 1,172,667 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.5% 1,172,667 0 1,172,667 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.5% 1,172,667 0 1,172,667 /s/ Israel A. Englander Israel A. Englander